TrialAmerican journal of hematology2018

Sorafenib Combined with 5-azacytidine in Older Patients with Untreated FLT3-ITD Mutated Acute Myeloid Leukemia.

Maro Ohanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.